Joshua Aymond
Clinical Cardiac Electrophysiology · Baton Rouge, LANPI 1144630369
Payments from drug & device makers
What this record shows
This record is dominated by grants: $39,750 of the $63,937 with a category attached, or 62.2%. 22 manufacturers reported payments, led by Abbott at 43.5% of the total. Reporting peaked in 2022 at $29,285 and has fallen 92.3% since, to $2,249 in 2025.
Across 352 payments — averaging $181.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$28K
- Medtronic$24K
- Biotronik Inc.$7K
- Boston Scientific$2K
- Johnson & Johnson$867
- AstraZeneca$720
- plus $3K from 16 others
What the payments were for
- Speaking & faculty fees$2,0193%
- Grants$39,75062%
- Travel & lodging$10,08716%
- Food & beverage$10,17416%
- Education$1,9063%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 63 | $27,834 |
| Medtronic | 47 | $23,519 |
| Biotronik Inc. | 52 | $6,925 |
| Boston Scientific | 14 | $1,551 |
| Johnson & Johnson | 52 | $867 |
| AstraZeneca | 30 | $720 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 7 | $532 |
| Pfizer | 15 | $278 |
| E.r. Squibb & Sons, L.L.C. | 20 | $252 |
| Biosense Webster, Inc. | 5 | $247 |
| Astellas Pharma US Inc | 7 | $245 |
| Amgen | 10 | $221 |
| Novartis | 10 | $204 |
| Irhythm Technologies, Inc. | 3 | $153 |
| Kestra Medical Technology Services, Inc. | 3 | $143 |
| Esperion Therapeutics, Inc. | 7 | $111 |
| Actelion Pharmaceuticals US, Inc. | 2 | $45 |
| Lantheus Medical Imaging, Inc. | 1 | $24 |
| Novo Nordisk | 1 | $20 |
| Endotronix, Inc. | 1 | $20 |
| Cook Medical LLC | 1 | $15 |
| Bayer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BioMonitor$1,862
- Solia$1,862
- Edora$1,828
- Rivacor$1,828
- Acticor$1,828
- ENSITE PRECISION$1,725
- AVEIR$1,682
- Micra$1,277
- EMBLEM MRI S-ICD$1,156
- Rivacor 7 DR-T$359
- Edora 8 DR-T$359
- Acticor 7 VR-T DX$359
- Sentus$324
- Plexa$324
- SelectSecure$298
- ENSITE$261
- EnSite Precision Cardiac Mapping System$246
- QUADRA ASSURA$138
- Carto 3$133
- ZIO XT Patch$128
How this compares
$63,937 in reported general payments places this provider in the 85th percentile of 43 clinical cardiac electrophysiology providers in Louisiana.
See all clinical cardiac electrophysiology providers in Louisiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 61 | $39,585 |
| MultaqDronedarone Hcl | 34 | $36,449 |
| Amiodarone Hcl | 78 | $1,134 |
| Flecainide Acetate | 40 | $895 |
| Metoprolol Succinate | 71 | $804 |
| Verapamil ErVerapamil Hcl | 11 | $389 |
| SotalolSotalol Hcl | 11 | $200 |
| Doxycycline Hyclate | 46 | $194 |
| Metoprolol Tartrate | 11 | $137 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 12 | $134 |
| Pantoprazole Sodium | 23 | $97 |
| Atorvastatin Calcium | 11 | $68 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $278 | $39,58561 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 43 clinical cardiac electrophysiology providers in Louisiana.
Other clinical cardiac electrophysiology in Baton Rouge
- Mark PolletBaton Rouge$90K
- Thomas GullattBaton Rouge$31K
- Kenneth CivelloBaton Rouge$30K
- Charles SmithBaton Rouge$29K
- Robert DrennanBaton Rouge$18K
- Paul DampfBaton Rouge$12K
- Wenjie XuBaton Rouge$10K
- Norman DeumiteBaton Rouge$9K
- Henry PatrickBaton Rouge$4K
- Nassir MarroucheNew Orleans$498K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.